The Efficacy and Safety of Systemic Antifungals in Children’s Onychomycosis

[1]  M. García-Romero,et al.  Onychomycosis in children. A review , 2017, International journal of dermatology.

[2]  L. Eichenfield,et al.  Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population , 2017, Pediatric dermatology.

[3]  A. Trickey,et al.  Trends in Pediatric Laboratory‐Diagnosed Onychomycosis Between 2006 and 2014 in the Southwest of England , 2016, Pediatric dermatology.

[4]  K. Foley,et al.  The prevalence of culture‐confirmed toenail onychomycosis in at‐risk patient populations , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  S. Friedlander,et al.  Antifungal therapy for onychomycosis in children. , 2015, Clinics in dermatology.

[6]  M. García-Romero,et al.  New insights into genes, immunity, and the occurrence of dermatophytosis. , 2015, The Journal of investigative dermatology.

[7]  V. Vicente,et al.  Onychomycosis by Fusarium oxysporum probably acquired in utero , 2014, Medical mycology case reports.

[8]  M. García-Romero,et al.  Onychomycosis in Immunosuppressed Children Receiving Chemotherapy , 2014, Pediatric dermatology.

[9]  A. Rubin,et al.  Diagnosis and management of nail disorders in children. , 2014, Pediatric clinics of North America.

[10]  J. Morelli,et al.  Onychomycosis in the Denver Pediatrics Population, A Retrospective Study , 2014, Pediatric dermatology.

[11]  M. Nucci,et al.  Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. , 2014, The Journal of infection.

[12]  D. Westerberg,et al.  Onychomycosis: Current trends in diagnosis and treatment. , 2013, American family physician.

[13]  A. Karaoğlu,et al.  Prevalence and risk factors of onychomycosis in primary school children living in rural and urban areas in Central Anatolia of Turkey. , 2013, Indian journal of dermatology, venereology and leprology.

[14]  Aditya K. Gupta,et al.  Therapies for the treatment of onychomycosis. , 2013, Clinics in dermatology.

[15]  Aditya K. Gupta,et al.  Systemic Antifungals to Treat Onychomycosis in Children: A Systematic Review , 2013, Pediatric dermatology.

[16]  A. Khalilian,et al.  Comparison of Diagnostic Methods in the Evaluation of Onychomycosis , 2013, Mycopathologia.

[17]  R. Arenas,et al.  Análisis del polimorfismo genético de los loci HLA-B y HLA-DR en pacientes con onicomicosis dermatofítica y familiares en primer grado , 2012 .

[18]  J. Granados,et al.  Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives. , 2012, Actas dermo-sifiliograficas.

[19]  J. Toribio,et al.  Onychomycosis observed in children over a 20‐year period , 2011, Mycoses.

[20]  T. Bieber,et al.  New reasons for histopathological nail‐clipping examination in the diagnosis of onychomycosis , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[21]  A. Tosti,et al.  An innovative water‐soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  N. Kogan,et al.  The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  A. Ingber,et al.  A Population‐based Study of Toenail Onychomycosis in Israeli Children , 2009, Pediatric dermatology.

[24]  M. Friedrich,et al.  Epidemiological trends in skin mycoses worldwide , 2008, Mycoses.

[25]  R. Arenas,et al.  Onicomicosis en niños. Estudio retrospectivo de 233 casos mexicanos , 2008 .

[26]  R. Arenas,et al.  [Onychomycosis among children. A retrospective study of 233 Mexican cases]. , 2008, Gaceta medica de Mexico.

[27]  A. Bonifaz,et al.  Dermatophyte onychomycosis in children under 2 years of age: experience of 16 cases , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  B. Sigurgeirsson,et al.  Onychomycosis in Icelandic children , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[29]  J. Roszkiewicz,et al.  Onychomycosis is no longer a rare finding in children , 2006, Mycoses.

[30]  B. Elewski,et al.  Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality , 2005, Therapeutics and clinical risk management.

[31]  C. Romano,et al.  Onychomycosis in children: a survey of 46 cases , 2005, Mycoses.

[32]  S. Avner,et al.  Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis , 2005, The Journal of dermatological treatment.

[33]  Andrew M. Johnson,et al.  Cumulative meta‐analysis of systemic antifungal agents for the treatment of onychomycosis , 2004, The British journal of dermatology.

[34]  Aditya K. Gupta,et al.  Onychomycosis in Children: A Brief Overview with Treatment Strategies , 2004, Pediatric dermatology.

[35]  B. Piraccini,et al.  Management of onychomycosis in children. , 2003, Dermatologic clinics.

[36]  Aditya K. Gupta,et al.  Onychomycosis in children: an overview. , 2003, Journal of drugs in dermatology : JDD.

[37]  I. Frieden,et al.  Rapid response of Trichophyton tonsurans‐induced onychomycosis after treatment with terbinafine , 2002, International journal of dermatology.

[38]  A. Barbaud,et al.  Epidemiology of Dermatophytoses in Children Living in Northeast France: A 5‐Year Study , 2002, Pediatric dermatology.

[39]  K. K. Mueller,et al.  Reversible agranulocytosis associated with oral terbinafine in a pediatric patient. , 2001, Journal of the American Academy of Dermatology.

[40]  J. del Pozo,et al.  Superficial white onychomycosis in a 3‐year‐old human immunodeficiency virus‐infected child , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[41]  J. Revuz,et al.  Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses. , 1998, European journal of dermatology : EJD.

[42]  A. Bonifaz,et al.  Onychomycosis in Children: Treatment with Bifonazole‐Urea , 2000, Pediatric dermatology.

[43]  P. Kullavanijaya,et al.  Onychomycosis in a 2-year-old child successfully treated with oral terbinafine. , 1998, Journal of the American Academy of Dermatology.

[44]  R. Summerbell,et al.  Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada ‐ a multicenter survey of 2001 patients , 1997, International journal of dermatology.

[45]  B. Elewski,et al.  Onychomycosis in children: prevalence and treatment strategies. , 1997, Journal of the American Academy of Dermatology.

[46]  T. Rantanen,et al.  A double‐blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe–nail onychomycosis , 1997, The British journal of dermatology.

[47]  H. Degreef,et al.  Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients. , 1997, Journal of the American Academy of Dermatology.

[48]  A. Lucky,et al.  Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature. , 1997, Journal of the American Academy of Dermatology.

[49]  A. Tosti,et al.  Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. , 1996, Journal of the American Academy of Dermatology.

[50]  M. Nijenhuis,et al.  Treatment of onychomycosis with terbinafine in patients with Down's syndrome , 1995, The British journal of dermatology.

[51]  V. Goulden,et al.  Treatment of Childhood Dermatophyte Infections with Oral Terbinafine , 1995, Pediatric dermatology.

[52]  B. Elewski.  Mechanisms of action of systemic antifungal agents. , 1993, Journal of the American Academy of Dermatology.

[53]  D. Nicholls,et al.  Onychomycosis caused by Trichophyton equinum , 1989, Clinical and experimental dermatology.